| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 1.5M | $15M | $10.00 | Jul 1, 2025 | By Ligand Pharmaceuticals Incorporated | ||
| Restricted Stock Units | 37K | $255K | $0.97 | Jul 2, 2025 | Direct | Common Stock | |
| Common Stock | 2.92K | $3.21K | $1.10 | Jul 1, 2025 | Direct | ||
| Series A Convertible Preferred Stock | 3.13M | Jul 1, 2025 | Indirect | Common Stock | |||
| Stock Option | 58.2K | Jul 2, 2025 | Direct | Common Stock |
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|